A new semisynthetic ergot derivative, Lisuride, has been administered to 40 women who wanted to have lactation inhibited. Purpose of the study was to evaluate the drug's effect on serum PRL levels. Treatment was carried out for 7 days with daily doses of 300 or 600 microgram. Lisuride lowered PRL levels, and the decrease was significantly more marked for the 600 microgram dose.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
prl levels
8
600 microgram
8
lisuride serum
4
serum prolactin
4
prolactin levels
4
levels puerperium
4
puerperium semisynthetic
4
semisynthetic ergot
4
ergot derivative
4
derivative lisuride
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!